{"id":"NCT01086423","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine","officialTitle":"Immunogenicity and Safety of GlaxoSmithKline Biologicals' DTPa-IPV/Hib (Infanrix-IPV+Hib™) in Infants","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03-01","primaryCompletion":"2010-11-19","completion":"2010-11-19","firstPosted":"2010-03-15","resultsPosted":"2017-04-10","lastUpdate":"2018-06-06"},"enrollment":985,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Tetanus","Poliomyelitis","Acellular Pertussis","Diphtheria","Haemophilus Influenzae Type b"],"interventions":[{"type":"BIOLOGICAL","name":"Infanrix-IPV/Hib™","otherNames":[]},{"type":"BIOLOGICAL","name":"Infanrix Hib™","otherNames":[]},{"type":"BIOLOGICAL","name":"Poliorix™","otherNames":[]}],"arms":[{"label":"INFANRIX-IPV+HIB 1 GROUP","type":"EXPERIMENTAL"},{"label":"INFANRIX-IPV+HIB 2 GROUP","type":"EXPERIMENTAL"},{"label":"INFANRIX-HIB+POLIORIX GROUP","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to evaluate the immunogenicity and reactogenicity of Infanrix-IPV/Hib™ vaccine when administered to healthy Chinese infants at 2, 3 and 4 or 3, 4 and 5 months of age.","primaryOutcome":{"measure":"Number of Seroprotected Subjects Against Diphtheria (D) and Tetanus (T) Antigens","timeFrame":"One month after the third vaccine dose (Month 3 or Month 4)","effectByArm":[{"arm":"Infanrix-IPV+Hib 1 Group","deltaMin":146,"sd":null},{"arm":"Infanrix-IPV+Hib 2 Group","deltaMin":156,"sd":null},{"arm":"Infanrix-Hib+Poliorix Group","deltaMin":147,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"60 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":11},"locations":{"siteCount":2,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":330},"commonTop":["Fever (Axillary)","Irritability","Loss of appetite","Drowsiness","Pain"]}}